Correlation Between Kymera Therapeutics and Kezar Life

Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kymera Therapeutics and Kezar Life Sciences, you can compare the effects of market volatilities on Kymera Therapeutics and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Kezar Life.

Diversification Opportunities for Kymera Therapeutics and Kezar Life

0.52

Correlation Coefficient

Kymera Therapeutics  Kezar Life

Very weak diversification

The 3 months correlation between Kymera and Kezar is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Kezar Life go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Kezar Life

Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.06 times more return on investment than Kezar Life. However, Kymera Therapeutics is 1.06 times more volatile than Kezar Life Sciences. It trades about 0.03 of its potential returns per unit of risk. Kezar Life Sciences is currently generating about 0.01 per unit of risk. If you would invest  3,713  in Kymera Therapeutics on February 3, 2024 and sell it today you would earn a total of  27.00  from holding Kymera Therapeutics or generate 0.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Kymera Therapeutics  vs.  Kezar Life Sciences

Kymera Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Kymera Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, Kymera Therapeutics may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Kezar Life Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kezar Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Kezar Life is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Kymera Therapeutics and Kezar Life

The main advantage of trading using opposite Kymera Therapeutics and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.

The idea behind Kymera Therapeutics and Kezar Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.